Loading...
XTAE
TGTR
Market cap18mUSD
Dec 04, Last price  
347.00ILS
1D
-1.76%
1Q
-8.90%
Jan 2017
-52.65%
Name

Together Pharma Ltd

Chart & Performance

D1W1MN
XTAE:TGTR chart
P/E
P/S
0.63
EPS
Div Yield, %
Shrs. gr., 5y
19.87%
Rev. gr., 5y
%
Revenues
96m
+5.55%
37,3371,189,3867,586,09612,114,113000011,223,00012,026,00031,228,00091,006,00096,053,000
Net income
-1m
L-72.85%
-12,970,873-4,483,606-5,470,405-3,838,052-1,733,760-34,000-149,863,000-15,276,0007,152,000-13,776,000-33,524,000-4,316,000-1,172,000
CFO
3m
-80.79%
-4,872,478-3,859,438-2,657,276-4,169,254-3,417,4330-5,379,000-6,833,000-9,703,000-18,644,000-13,733,00014,831,0002,849,000
Dividend
Mar 29, 20111.5089 ILS/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Together Pharma Ltd, through its subsidiaries, engages in growing, production, storage, and distribution of medical cannabis products in Israel. The company was incorporated in 1991 and is based in Ashkelon, Israel.
IPO date
May 01, 1993
Employees
70
Domiciled in
IL
Incorporated in
IL

Valuation

Title
ILS in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT